Faculty Bibliography

The difficult rehabilitation that President Clinton will face after knee surgery today is discussed. For the next eight weeks or so, Mr. Clinton, who is 50, will be on crutches to keep some weight off his injured leg, Dr. David P. Adkison, the orthopedic surgeon who performed the operation, said at a news conference at the National Naval Medical Center. Through an audio link, Mr. Clinton interrupted the news conference to tell reporters not to give his doctors a hard time about his plans to fly to Helsinki, Finland, on Tuesday for a summit meeting with Boris N. Yeltsin, the Russian President. The meeting will accommodate two ailing leaders. Mr. Yeltsin, 66, is recovering from a heart bypass operation and pneumonia. The tendon joins four muscles in the upper leg and attaches to the kneecap. More than 50 percent of Mr. Clinton's tendon was torn, and the tear was in a pattern that was more complex than usual, Dr. Adkison said. However, that is not expected to prolong Mr. Clinton's rehabilitation. Before the surgery, Mr. Clinton was shown pictures of the damage to his knee

Dr. Waldo E. Nelson, the author of the leading textbook of pediatrics for 40 years, died on March 2 at his home in Gladwyne, Pa. He was 98. A distinguished medical educator, Dr. Nelson was the chairman of the department of pediatrics at Temple University and the medical director of St. Christopher's Hospital, both in Philadelphia. Many doctors trained by Dr. Nelson are now leaders in pediatrics. Dr. Nelson was also the editor of The Journal of Pediatrics from 1959 through 1978. However, Dr. Nelson was even better known to generations of doctors whom he did not train directly through the classic textbook he wrote, now known as the ''Nelson Textbook of Pediatrics.''

The national decline in AIDS deaths confirms the trend that New York City health officials reported last month in announcing that their figures for all of 1996 showed the first documented drop in AIDS deaths anywhere in the country -- while the number of AIDS cases nationwide is rising. Today's report refuted some experts who suggested that the improvement in New York City was an isolated phenomenon or was due to incomplete reporting or a statistical quirk. One notable difference between the New York City and national figures is that, for unknown reasons, deaths from AIDS for women rose 3 percent in the national data while AIDS deaths of women in New York City dropped 24.5 percent. Officials at the Federal health agency, in Atlanta, like those at the New York City Health Department, said the drop in deaths was probably due in large part to the success of drug therapies introduced over recent years to fight H.I.V., the virus that causes AIDS, and the many potentially fatal complications of AIDS through opportunistic infections

About 70 percent of the drop in the number of deaths from coronary artery disease can be attributed to use of clot-dissolving drugs, like streptokinase and tissue plasminogen activator, and procedures like angioplasty and bypass surgery for people with coronary artery disease, according to the study, published today in The Journal of the American Medical Association. Dietary changes in the general population aimed at preventing coronary artery disease accounted for only about 25 percent of the drop between 1980 and 1990, said the study's lead author, Dr. Maria G. M. Hunink, of the Harvard School of Public Health and University of Groningen in the Netherlands. Dr. Hunink said in a telephone interview from Groningen that her team had been ''amazed'' to learn that medical treatment had a larger impact than prevention on the incidence of coronary artery disease, the most common type of heart disease. It remains the leading cause of death of Americans, despite a decline of from 2 to 4 percent each year in recent years in this country

Medical treatment has been much more important in the decline of heart-disease deaths than widespread changes in diet and other means of prevention, a statistical study has found. About 70 percent of the drop in the number of deaths from coronary artery disease can be attributed to use of clot-dissolving drugs and procedures such as angioplasty and bypass surgery, according to the study, published today in The Journal of the American Medical Association. Dietary changes in the general population aimed at preventing coronary artery disease accounted for about 25 percent of the drop between 1980 and 1990, said the study's lead author, Dr. Maria G.M. Hunink of the Harvard School of Public Health and the University of Groningen in the Netherlands

A major AIDS meeting ended here today with the hope that some of the experimental drugs reported on will ultimately ease the burden of patients who must adhere to difficult regimens when they take the drugs that are now available. Speakers at the meeting, which drew more than 2,300 AIDS experts and other scientists, said they had been astonished by the favorable turn of events since last year's AIDS conference, when combination drug therapies were first shown to be able to suppress H.I.V., the virus that causes AIDS, below the limits of detection. The combination therapies use older drugs like AZT and a new class of drugs, protease inhibitors. Many participants said they had come to believe that when a therapy failed in a patient, any newly prescribed regimen should include at least two drugs that the patient had never taken. However, that strategy cannot work for the many patients who have taken virtually every licensed and experimental drug and who desperately need new drugs, Dr. Harvey J. Makadon, an AIDS expert at Beth Israel Hospital in Boston, said in an interview

A major AIDS meeting ended here yesterday with the hope that some of the experimental drugs reported on will ultimately ease the burden of patients who must adhere to difficult regimens when they take the drugs that are now available. Speakers at the meeting, which drew more than 2,300 AIDS experts and other scientists, said they had been astonished by the favorable turn of events since last year's AIDS conference, when combination drug therapies were first shown to be able to suppress HIV, the virus that causes AIDS, below the limits of detection. The combination therapies use older drugs like AZT and a new class of drugs, protease inhibitors

When [Paul E. Tsongas] ran unsuccessfully for the Democratic nomination in the 1992 presidential campaign, he made an issue of his survival from a form of cancer known as non-Hodgkin's lymphoma. But Tsongas and his doctors at the Dana-Farber Cancer Institute in Boston, Ronald W. Takvorian and George P. Canellos, repeatedly said he had been cancer-free when he had not. In so doing, they implied that the cancer was cured when indeed it was not curable. Tsongas' death Jan. 18 from pneumonia at age 55 came two days shy of what would have been a full term. The pneumonia was the final, fatal complication of many complications for treatment for non-Hodgkin's lymphoma that he had battled since 1983. In his fight, Tsongas underwent two bone marrow transplants, in 1986 and last May. PHOTO 1 PHOTO 2; Caption: Ex-Sen. Paul E. Tsongas appears at a medical conference in November, less than two months before his death. Handicap: If Paul E. Tsongas, shown campaigning for president in Baltimore, had won, he might have have been forced by his illness to resign, been unable to run again or have died in office.; Credit: ASSOCIATED PRESS ASSOCIATED PRESS: 1992